A Study to Evaluate the Efficacy and Safety of Epinastine Hydrochloride Eye Drops in the Treatment of Chinese Seasonal Allergic Conjunctivitis Patients
Clinical trial NCT06212973 · COMPLETED
Trial details
- NCT number
- NCT06212973
- Sponsor
- Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-13
- Primary completion
- 2023-11-02
- Enrollment
- 266
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.